Amgen earnings per share up 20 percent due to higher product sales

You are here: Home > Central Coast Health Watch > Current Article

Amgen earnings per share up 20 percent due to higher product sales

By Staff Report / Thursday, July 26th, 2018 / Comments Off on Amgen earnings per share up 20 percent due to higher product sales

Thousand oaks-based biotech giant Amgen reported a steep increase in second quarter earnings per share on higher product sales and strong performance from its newer products. Earnings per share rose 20 percent compared to the previous second quarter to $3.48 after share buybacks and a lower tax rate compared to 2017. Repatha sales grew nearly…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.